Steinman L, Waisman A, Altmann D
Department of Neurologic Sciences, Beckman Center for Molecular and Genetic Medicine, Stanford University, Stanford, CA 94305, USA.
Mol Med Today. 1995 May;1(2):79-83. doi: 10.1016/s1357-4310(95)92366-7.
Evidence is emerging that the major T- and B-cell response in multiple sclerosis (MS) is directed to a region of myelin basic protein (MBP) between residues 84 and 103. In rodent models of MS, immunization to this component of MBP evokes experimental autoimmune encephalomyelitis (EAE). T cells found in EAE lesions show similarities in the VJ and VDJ regions of their alpha and beta chains with T cells in MS lesions, and with T cells that are specific for MBPp84-103 isolated from patients with MS. If this region of MBP is critical in the pathogenesis of MS, then therapy aimed at controlling the immune response to this immunodominant region of MBP may be beneficial in treating MS.
越来越多的证据表明,多发性硬化症(MS)中主要的T细胞和B细胞反应针对的是髓鞘碱性蛋白(MBP)第84至103位残基之间的区域。在MS的啮齿动物模型中,针对MBP这一成分的免疫会引发实验性自身免疫性脑脊髓炎(EAE)。在EAE病变中发现的T细胞,其α和β链的VJ和VDJ区域与MS病变中的T细胞以及从MS患者中分离出的对MBPp84 - 103特异的T细胞相似。如果MBP的这一区域在MS发病机制中起关键作用,那么旨在控制针对MBP这一免疫显性区域的免疫反应的疗法可能对治疗MS有益。